Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack.
Studies on erythrocytes have shown that the formation of the membrane attack complex on a cell surface inevitably results in lysis. However, it is known that nucleated cells are much more difficult to kill with complement, although the molecular basis of this resistance has never been established. We have shown that a very early intracellular event, occurring within seconds of formation of the attack complex in the membrane, is a rise in cytoplasmic Ca2+, which can activate cell responses without cell death 5,6. Here we report the use of a monoclonal antibody to the terminal complement component C9, quantified by 125I and visualized by fluorescein, to demonstrate a protection mechanism in polymorphonuclear leukocytes (PMNs) attacked by complement, involving removal of the attack complex by vesiculation. Concomitantly, there is a Ca2+-dependent activation of reactive oxygen metabolite production without cell lysis. These findings have important implications in the evolutionary and pathological significance of the terminal components of the complement pathway.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D002118:Calcium / Q000502:physiology; D002462:Cell Membrane / Q000276:immunology; D003186:Complement C9 / Q000276:immunology*; D006801:Humans; D009504:Neutrophils / Q000276:immunology*; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D013696:Temperature
D000911:Antibodies, Monoclonal; D003186:Complement C9; D010100:Oxygen; D002118:Calcium